Kees Roks

Kees Roks is the Head of the European Oncology Business at Novartis, overseeing a dedicated team across 51 countries to innovate in the field of medicine. With a career spanning back to 1985, Kees has gained extensive international experience across various markets and cultures, emphasizing the importance of access, affordability, and care.

Kees Roks is a member of the EFPIA Patient Access Committee, the EU Cancer Mission Assembly, and the Scientific Advisory Board for the Open Research Europe initiative under the European Commission. His commitment to advancing healthcare access is reflected not only in his professional roles but also through his active involvement in key committees and boards.

Having studied Business Administration at Eindhoven University of Technology, Kees Roks brings a solid educational foundation to his leadership role in the pharmaceutical industry. His tenure at Novartis includes positions such as Head Region Europe, Region Head Latin America & Canada, Head Western Europe at Novartis Oncology, General Manager in various locations, and roles in marketing, sales, and business units, showcasing his diverse skill set and experience.

Through his multifaceted roles, Kees Roks has demonstrated a deep understanding of the pharmaceutical landscape, leading teams and driving initiatives that aim to enhance patient care and facilitate the development and accessibility of innovative treatments.